{"id":"https://openalex.org/W1963995164","doi":"https://doi.org/10.1007/s10637-009-9383-9","title":"A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer","display_name":"A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer","publication_year":2010,"publication_date":"2010-01-18","ids":{"openalex":"https://openalex.org/W1963995164","doi":"https://doi.org/10.1007/s10637-009-9383-9","mag":"1963995164","pmid":"https://pubmed.ncbi.nlm.nih.gov/20084425","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4331064"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-009-9383-9","doi":"https://doi.org/10.1007/s10637-009-9383-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-009-9383-9","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4331064","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089732639","display_name":"Qing Hua Zhou","orcid":"https://orcid.org/0000-0002-0478-176X","observed_orcids":["https://orcid.org/0000-0002-0478-176X","https://orcid.org/0000-0002-0586-345X"]},"institutions":[{"id":"https://openalex.org/I2799425052","display_name":"Guangdong General Hospital","ror":"https://ror.org/03jpekd50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2799425052"]},{"id":"https://openalex.org/I4210145693","display_name":"Guangdong Academy of Medical Sciences","ror":"https://ror.org/0432p8t34","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210145693"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Qing Zhou","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO 80045, USA","Guangdong General Hospital & Guangdong Academy of Medical Sciences","University of Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Guangdong General Hospital & Guangdong Academy of Medical Sciences","institution_ids":["https://openalex.org/I2799425052","https://openalex.org/I4210145693"]},{"raw_affiliation_string":"University of Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072152051","display_name":"Daniel L. Gustafson","orcid":"https://orcid.org/0000-0002-3063-1669","observed_orcids":["https://orcid.org/0000-0002-3063-1669"]},"institutions":[{"id":"https://openalex.org/I92446798","display_name":"Colorado State University","ror":"https://ror.org/03k1gpj17","country_code":"US","type":"education","lineage":["https://openalex.org/I92446798"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Gustafson","raw_affiliation_strings":["University of Colorado Comprehensive Cancer Center Pharmacology Core, Colorado State University, Fort Collins, CO, 80523-1620, USA","University of Colorado Comprehensive Cancer Center Pharmacology Core, Colorado State University, Fort Collins, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Comprehensive Cancer Center Pharmacology Core, Colorado State University, Fort Collins, CO, 80523-1620, USA","institution_ids":["https://openalex.org/I92446798"]},{"raw_affiliation_string":"University of Colorado Comprehensive Cancer Center Pharmacology Core, Colorado State University, Fort Collins, USA","institution_ids":["https://openalex.org/I92446798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070613822","display_name":"Sujatha Nallapareddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sujatha Nallapareddy","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058784740","display_name":"Sami Diab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sami Diab","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103144296","display_name":"Stephen Leong","orcid":"https://orcid.org/0000-0002-8838-8542","observed_orcids":["https://orcid.org/0000-0002-8838-8542"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Leong","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010628808","display_name":"Karl D. Lewis","orcid":"https://orcid.org/0000-0001-9893-0537","observed_orcids":["https://orcid.org/0000-0001-9893-0537"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl Lewis","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037169725","display_name":"Lia Gore","orcid":"https://orcid.org/0000-0002-2546-4616","observed_orcids":["https://orcid.org/0000-0002-2546-4616"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lia Gore","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078259926","display_name":"Wells A. Messersmith","orcid":"https://orcid.org/0000-0003-2349-0885","observed_orcids":["https://orcid.org/0000-0003-2349-0885"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wells A. Messersmith","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077585632","display_name":"Anthony M. Treston","orcid":"https://orcid.org/0000-0001-7497-8253","observed_orcids":["https://orcid.org/0000-0001-7497-8253"]},"institutions":[{"id":"https://openalex.org/I4210118794","display_name":"CASI Pharmaceuticals (United States)","ror":"https://ror.org/02xbbj940","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118794"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony M. Treston","raw_affiliation_strings":["EntreMed, Inc., Research Triangle Park Center, 4819 Emperor Boulevard, Suite 400, Durham, NC, 27703, USA","EntreMed, Inc, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EntreMed, Inc., Research Triangle Park Center, 4819 Emperor Boulevard, Suite 400, Durham, NC, 27703, USA","institution_ids":["https://openalex.org/I4210118794"]},{"raw_affiliation_string":"EntreMed, Inc, Durham, USA","institution_ids":["https://openalex.org/I4210118794"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046581734","display_name":"Sabine Eckhardt","orcid":"https://orcid.org/0000-0001-6958-5375","observed_orcids":["https://orcid.org/0000-0001-6958-5375"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Gail Eckhardt","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068785261","display_name":"Carolyn Fowler Sidor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118794","display_name":"CASI Pharmaceuticals (United States)","ror":"https://ror.org/02xbbj940","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118794"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn Sidor","raw_affiliation_strings":["EntreMed, Inc., Research Triangle Park Center, 4819 Emperor Boulevard, Suite 400, Durham, NC, 27703, USA","EntreMed, Inc, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EntreMed, Inc., Research Triangle Park Center, 4819 Emperor Boulevard, Suite 400, Durham, NC, 27703, USA","institution_ids":["https://openalex.org/I4210118794"]},{"raw_affiliation_string":"EntreMed, Inc, Durham, USA","institution_ids":["https://openalex.org/I4210118794"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082517668","display_name":"D. Ross Camidge","orcid":"https://orcid.org/0000-0003-3430-3213","observed_orcids":["https://orcid.org/0000-0003-3430-3213"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"D. Ross Camidge","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","University of Colorado Comprehensive Cancer Center, MSF704, 1665 Aurora Court, Aurora, CO, 80045, USA","University of Colorado Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Medical Oncology, University of Colorado, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I51713134"]},{"raw_affiliation_string":"University of Colorado Comprehensive Cancer Center, MSF704, 1665 Aurora Court, Aurora, CO, 80045, USA","institution_ids":["https://openalex.org/I4210134151"]},{"raw_affiliation_string":"University of Colorado Comprehensive Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5082517668"],"corresponding_institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":3.5939,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.9327978,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"29","issue":"2","first_page":"340","last_page":"346"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.5839999914169312,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.5839999914169312,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.05900000035762787,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.03739999979734421,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-methoxyestradiol","display_name":"2-methoxyestradiol","score":0.9020000100135803},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.7770000100135803},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.6370000243186951},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7129999995231628},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9319999814033508},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7609999775886536},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8980000019073486},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.7580000162124634},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.6650000214576721},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7279999852180481},{"id":"https://openalex.org/keywords/neuroendocrine-carcinoma","display_name":"neuroendocrine carcinoma","score":0.6050000190734863},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":1.0}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7987281084060669},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6866233348846436},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6818002462387085},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5586430430412292},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5489127039909363},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5286874175071716},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4726359248161316},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.46489468216896057},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45416101813316345},{"id":"https://openalex.org/C2776260442","wikidata":"https://www.wikidata.org/wiki/Q4596897","display_name":"2-Methoxyestradiol","level":3,"score":0.4478491544723511},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42212191224098206},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4166867733001709},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.32224518060684204},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3102905750274658},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.3102042078971863}],"mesh":[{"descriptor_ui":"D000077584","descriptor_name":"2-Methoxyestradiol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003710","descriptor_name":"Demography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004963","descriptor_name":"Estrenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004963","descriptor_name":"Estrenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004963","descriptor_name":"Estrenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004963","descriptor_name":"Estrenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s10637-009-9383-9","doi":"https://doi.org/10.1007/s10637-009-9383-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-009-9383-9","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:20084425","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20084425","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:europepmc.org:3296228","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4331064","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4331064","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4331064","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Invest New Drugs","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3296228","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4331064","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8399999737739563,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G9000891461","display_name":"University of Colorado Cancer Center Support Grant","funder_award_id":"P30CA046934","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309627","display_name":"Colorado State University","ror":"https://ror.org/03k1gpj17"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W126259857","https://openalex.org/W1983964043","https://openalex.org/W2006760151","https://openalex.org/W2031249491","https://openalex.org/W2047817078","https://openalex.org/W2060240525","https://openalex.org/W2075488301","https://openalex.org/W2096178119","https://openalex.org/W2107846985","https://openalex.org/W2121090512","https://openalex.org/W2139711019","https://openalex.org/W2166435019","https://openalex.org/W2168323912","https://openalex.org/W2769371621"],"related_works":["https://openalex.org/W2546231032","https://openalex.org/W2107846985","https://openalex.org/W754991543","https://openalex.org/W2342168811","https://openalex.org/W2003292783","https://openalex.org/W2075488301","https://openalex.org/W2168229293","https://openalex.org/W2581337018","https://openalex.org/W2139149338","https://openalex.org/W2105421288"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}